Effect of Hydrocolloid Dressing and Terpolymer-Based Alcohol-Free Barrier Film on Pain During Tape Removal in Nasogastric Tube Fixation in Infants: A Randomized Controlled Trial.

Adv Skin Wound CareJun 25, 2026 (epub)
Clinical ResearchPediatrics

Özge Eren, Çağrı Çövener Özçelik

✦ AI-curated · Sources linked

In 30 seconds

This randomized controlled trial evaluated the impact of hydrocolloid dressing and terpolymer-based alcohol-free barrier film on pain during silk tape removal in 120 infants aged 4 to 6 weeks. The study found that pain levels were significantly lower with the terpolymer-based film compared to hydrocolloid dressing, with a P-value of <.001 indicating strong statistical significance.

Key findings

  • Pain level following hydrocolloid dressing was 2 times higher than with silk tape (P <.001).
  • Pain persisted in the silk tape group even 3 minutes post-procedure (P <.01).
  • Silk tape fixation was 3 times higher than terpolymer-based alcohol-free barrier film.

Why it matters

Understanding effective pain management strategies in infants is crucial for improving patient comfort and outcomes. This study highlights the importance of using protective products to minimize pain during medical procedures.

Source

PubMed · PMID 42340166

Published in Adv Skin Wound Care. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Pediatrics

Clinical ResearchOncology (Medical)

Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.

DALY 2-EU was an open-label, multicentre, randomised phase 2 trial comparing tandem CD20-CD19-directed zamtocabtagene autoleucel (zamto-cel) with R-GemOx in adults with second-line relapsed or refractory large B-cell…

Lancet OncolOct 27, 2026Read summary
Clinical ResearchOncology (Medical)

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial.

UNION was a multicentre, open-label, randomised phase 3 trial at nine hospitals in China comparing neoadjuvant short-course radiotherapy followed by camrelizumab plus CAPOX with long-course chemoradiotherapy followed by…

Lancet OncolOct 25, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.